Certara, Inc.
Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation s…
Medical - Healthcare Information Services
US, Princeton [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
Fundamentals
Valuation
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| EV/EBITDA | -34.54 | 174.70 | 266.88 | |
| Graham Fair Price | -38.50 | 2.09 | 3.40 | |
| PEG | 226.72 | 2.46 | 0.75 | |
| Price/Book | 1.66 | 2.72 | 2.68 | |
| Price/Cash Flow | 2603.38 | 3999.22 | 147.93 | |
| Prices/Earnings | -172.34 | -153.29 | -56.29 | |
| Price/Sales | -6.77 | 29.71 | 31.86 | |
| Price/FCF | 2603.38 | 3999.22 | 147.93 | |
| Naive Interpretation | member | |||
01 - Valuation ·
Weak
Fundamentals
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Profit Margin | -3.41 | 0.46 | 0.48 | |
| Operating Margin | -89.35 | < 0.005 | -0.05 | |
| ROA | 61.90 | < 0.005 | < 0.005 | |
| ROE | -0.01 | < 0.005 | 62.67 | |
| ROIC | < 0.005 | < 0.005 | -90.07 | |
| Naive Interpretation | member | |||
02 - Profitability ·
Not Interpreted
Fundamentals
Financial Growth
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Debt QOQ | 0.03 | -0.02 | 68.51 | |
| Dividends QOQ | 0.00 | 0.00 | 0.00 | |
| EBIT QOQ | 0.92 | 1.12 | 21.07 | |
| EPS QOQ | 0.75 | 0.62 | -16.64 | |
| FCF QOQ | -0.31 | -0.96 | -212.93 | |
| Revenue QOQ | 0.03 | 0.10 | 245.31 | |
| Naive Interpretation | member | |||
03 - Financial Growth ·
Weak
Fundamentals
Leverage & Liquidity
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Assets Turnover | n.A. | n.A. | n.A. | |
| Days Inventory Outstanding (DIO) | -8.72 | -8.66 | 0.61 | |
| Days Sales Outstanding (DSO) | 95.36 | 83.01 | -12.95 | |
| Inventory Turnover | -10.32 | -10.39 | -0.61 | |
| Debt/Capitalization | 0.22 | 0.22 | 0.48 | |
| Quick Ratio | 2.56 | 3.17 | 23.88 | |
| Naive Interpretation | member | |||
04 - Leverage & Liquidity ·
Weak
Fundamentals
Per Share Metrics
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | 6.57 | 6.61 | 0.66 | |
| Cash | 1.50 | 1.44 | -4.07 | |
| Capex | -0.03 | -0.02 | 18.15 | |
| Free Cash Flow | 0.12 | < 0.005 | -96.21 | |
| Revenue | 0.55 | 0.61 | 9.76 | |
| Naive Interpretation | member | |||
05 - Per Share Metrics ·
Weak
Fundamentals
Financial Health
06 - Financial Health ·
Bad